Markus I Anzaldua-Campos

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Binding Protein

African American

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler, Ngima D Sherpa, Lydia A Leavitt, Alexandra J Livingstone, Saad M Khan, Mao Li, Markus I Anzaldua-Campos, Joseph D Bradley, Eric C Leuthardt, Albert H Kim, Joshua L Dowling, Michael R Chicoine, Pamela Stuart Jones, Bryan D Choi, Daniel P Cahill, Bob S Carter, Allegra A Petti, Tanner M Johanns, Gavin P Dunn
Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population. Cancer discovery (2024)
Anthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler, Ngima D Sherpa, Lydia A Leavitt, Alexandra J Livingstone, Saad M Khan, Mao Li, Markus I Anzaldua-Campos, Joseph D Bradley, Eric C Leuthardt, Albert H Kim, Joshua L Dowling, Michael R Chicoine, Pamela Stuart Jones, Bryan D Choi, Daniel P Cahill, Bob S Carter, Allegra A Petti, Tanner M Johanns, Gavin P Dunn
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population. Cancer discovery 14 (6) (2024)
Anthony Z Wang, Bryce L Mashimo, Maximilian O Schaettler, Ngima D Sherpa, Lydia A Leavitt, Alexandra J Livingstone, Saad M Khan, Mao Li, Markus I Anzaldua-Campos, Joseph D Bradley, Eric C Leuthardt, Albert H Kim, Joshua L Dowling, Michael R Chicoine, Pamela Stuart Jones, Bryan D Choi, Daniel P Cahill, Bob S Carter, Allegra A Petti, Tanner M Johanns, Gavin P Dunn
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population. Cancer discovery 14 (6) (2024)